Clinical Trial Update: 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 99mTc-rhAnnexin V-128 for diagnosing spondyloarthritis was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis

Drugs mentioned

• 99mTc-rhAnnexin V-128 (rhAnnexin V-128)

Snippet

Sponsor: Advanced Accelerator Applications | Conditions: Spondyloarthritis | Phase 2 | Status: TERMINATED | Results posted: 2019-12-13